Cargando…
Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
The risk of neuromuscular blockade is certainly minimized by sugammadex in combination with monitoring. However, the effect of sugammadex-aided recovery on patients’ satisfaction is unclear. This study compared the Quality of Recovery (QoR)-15 score, which is a patient-reported outcome, in patients...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957716/ https://www.ncbi.nlm.nih.gov/pubmed/33804329 http://dx.doi.org/10.3390/jcm10050938 |
_version_ | 1783664713227304960 |
---|---|
author | Han, Jiwon Oh, Ah-Young Jeon, Yong-Tae Koo, Bon-Wook Kim, Bo Young Kim, Donghyun Hwang, Insung |
author_facet | Han, Jiwon Oh, Ah-Young Jeon, Yong-Tae Koo, Bon-Wook Kim, Bo Young Kim, Donghyun Hwang, Insung |
author_sort | Han, Jiwon |
collection | PubMed |
description | The risk of neuromuscular blockade is certainly minimized by sugammadex in combination with monitoring. However, the effect of sugammadex-aided recovery on patients’ satisfaction is unclear. This study compared the Quality of Recovery (QoR)-15 score, which is a patient-reported outcome, in patients undergoing laparoscopic cholecystectomy. Eighty patients were randomly assigned to the neostigmine or sugammadex groups. At the end of surgery, neostigmine or sugammadex was administered, and tracheal extubation was performed after confirmation of a train of four ratio ≥ 0.9. The QoR-15 questionnaire was administered at 1 day before surgery and on post-operative days (POD) 1 and 2. The primary outcome was the QoR-15 score on POD 1. The secondary outcomes were the QoR-15 score on POD 2, modified Aldrete score, length of post-anesthetic care unit stay, post-operative pain, administration of anti-emetics, urinary retention, and length of hospital stay. No significant differences were found in QoR-15 scores on POD 1 (94.4 vs. 95.5, p = 0.87) or 2 (116.3 vs. 122, p = 0.33). Secondary outcomes were also comparable, with the exception of urinary retention (15.8% neostigmine vs. 2.6% sugammadex, p = 0.04). This study demonstrated that the quality of recovery was comparable between the neostigmine and sugammadex groups when reversal and tracheal extubation were performed in accordance with the current guidelines. |
format | Online Article Text |
id | pubmed-7957716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79577162021-03-16 Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial Han, Jiwon Oh, Ah-Young Jeon, Yong-Tae Koo, Bon-Wook Kim, Bo Young Kim, Donghyun Hwang, Insung J Clin Med Article The risk of neuromuscular blockade is certainly minimized by sugammadex in combination with monitoring. However, the effect of sugammadex-aided recovery on patients’ satisfaction is unclear. This study compared the Quality of Recovery (QoR)-15 score, which is a patient-reported outcome, in patients undergoing laparoscopic cholecystectomy. Eighty patients were randomly assigned to the neostigmine or sugammadex groups. At the end of surgery, neostigmine or sugammadex was administered, and tracheal extubation was performed after confirmation of a train of four ratio ≥ 0.9. The QoR-15 questionnaire was administered at 1 day before surgery and on post-operative days (POD) 1 and 2. The primary outcome was the QoR-15 score on POD 1. The secondary outcomes were the QoR-15 score on POD 2, modified Aldrete score, length of post-anesthetic care unit stay, post-operative pain, administration of anti-emetics, urinary retention, and length of hospital stay. No significant differences were found in QoR-15 scores on POD 1 (94.4 vs. 95.5, p = 0.87) or 2 (116.3 vs. 122, p = 0.33). Secondary outcomes were also comparable, with the exception of urinary retention (15.8% neostigmine vs. 2.6% sugammadex, p = 0.04). This study demonstrated that the quality of recovery was comparable between the neostigmine and sugammadex groups when reversal and tracheal extubation were performed in accordance with the current guidelines. MDPI 2021-03-01 /pmc/articles/PMC7957716/ /pubmed/33804329 http://dx.doi.org/10.3390/jcm10050938 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Han, Jiwon Oh, Ah-Young Jeon, Yong-Tae Koo, Bon-Wook Kim, Bo Young Kim, Donghyun Hwang, Insung Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial |
title | Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial |
title_full | Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial |
title_fullStr | Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial |
title_full_unstemmed | Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial |
title_short | Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial |
title_sort | quality of recovery after laparoscopic cholecystectomy following neuromuscular blockade reversal with neostigmine or sugammadex: a prospective, randomized, controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957716/ https://www.ncbi.nlm.nih.gov/pubmed/33804329 http://dx.doi.org/10.3390/jcm10050938 |
work_keys_str_mv | AT hanjiwon qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial AT ohahyoung qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial AT jeonyongtae qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial AT koobonwook qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial AT kimboyoung qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial AT kimdonghyun qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial AT hwanginsung qualityofrecoveryafterlaparoscopiccholecystectomyfollowingneuromuscularblockadereversalwithneostigmineorsugammadexaprospectiverandomizedcontrolledtrial |